MedPath

Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

Phase 2
Conditions
Xerostomia
Registration Number
NCT00408759
Lead Sponsor
Bnai Zion Medical Center
Brief Summary

xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.

hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.

Detailed Description

10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • radiotherapy for head and neck cancer
  • xerostomia
Exclusion Criteria
  • psychiatric illness (present or past)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
salivaa volume
quality of life related to salivation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

bnai zion MC

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath